MediWound Ltd.
YAVNE, L3 · CIK 0001593984 · Biotech · Public
Enzymatic biological drugs for selective eschar and wound debridement
mediwound.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $31M
- 2 Form D · Oct 2022
- 48 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 2 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $13,257,148 | |
| Private capital raised | Form D · SEC | $17,242,852 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2379 | ISIS PHARMACEUTICALS INC | — | $201M |
| 2380 | MANUS BIO INC | — | $109M |
| 2381 | Jaguar Health, Inc. | — | $146M |
| 2382 | MediWound Ltd. | — | $31M |
| 2383 | SALIX PHARMACEUTICALS LTD | — | $750M |
| 2384 | Stemsynergy Therapeutic | — | — |
| 2385 | HiberCell | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Vickie DriverDirector
- David FoxDirector
- Ofer GonenExecutive Officer
- Boaz Gur-LavieExecutive Officer
- Ety KlingerDirector · Executive Officer
- Sharon KochanDirector
- Sharon MalkaDirector
- Nissim MashiachDirector
- Yaron MeyerExecutive Officer
- Tzvi PalashExecutive Officer
- Lior RosenbergExecutive Officer
- Assaf SegalDirector
- Nachum (Homi) ShamirDirector
- Stephen WillsDirector
Patents
- Methods Of Debridement Of Chronic Woundsapplication
- Proteolytic Enzyme Mixture For Treating Psoriasisapplication
- Methods Of Treating Skin Cancersapplication
- Debriding Composition For Treating Woundsgranted
- Proteolytic Extract From Bromelain For The Treatment Of Connective Tissue Disordersgranted
- Methods Of Debridement Of Chronic Woundsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.